+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Amikacin"

Aminoglycosides Global Market Report 2024 - Product Thumbnail Image

Aminoglycosides Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
2021 Amikacin Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2021 Amikacin Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2021
  • United States, Europe, ... United States, Europe, Japan
From
2020 Amikacin Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Amikacin Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Europe, Japan, United States Europe, Japan, United States
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Amikacin is an aminoglycoside antibiotic used to treat a wide range of bacterial infections. It is effective against both gram-positive and gram-negative bacteria, and is often used in combination with other antibiotics. Amikacin is typically administered intravenously or intramuscularly, and is available in both generic and branded formulations. It is commonly used to treat infections of the urinary tract, respiratory tract, and skin and soft tissue. Amikacin is a widely used antibiotic, and is available in many countries around the world. It is often used in combination with other antibiotics, and is generally well tolerated with few side effects. It is also relatively inexpensive, making it an attractive option for treating bacterial infections. Some companies in the Amikacin market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Novartis. Show Less Read more